Purpose
to evaluate a new tuberculosis diagnostic and RIF-resistance molecular test in a multicenter clinical trial to generate evidence in support of WHO review
Grantee
Division
Global Health
Date
DECEMBER 2018
Region served
GLOBAL
Committed amount
$1,689,805
Grant topic
Tuberculosis
Duration (months)
27
Grantee location
Geneva, Switzerland
Related work
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.